Bimekizumab (Bimzelx; UCB Pharma) was approved by the FDA to treat psoriatic arthritis (PsA) on September 23, 2024, based on ...

Topline data were announced from two phase 3 trials evaluating deucravacitinib in adults with active psoriatic arthritis.

For patients with psoriatic arthritis, switching directly from adalimumab to tofacitinib with no washout period presents no ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

The NHS says psoriatic arthritis is a long-term condition that causes joint pain, swelling and stiffness. Medicines can help treat the symptoms. Some people with the skin condition psoriasis may ...

Diseases of the joints are known as arthritis. The term is derived from the Greek word that means exactly that: diseases of ...

In fact, research finds that more than 90 percent of people who include stretches in their plantar fasciitis treatment plan feel less heel pain. But stretching is only one piece of a plantar ...

To that end, the company has reported positive results for two phase 3 trials of Sotyktu in adult patients who have psoriatic arthritis (PsA). Without revealing figures, BMS said that the POETYK ...

Learn about rheumatoid vasculitis, neutrophilic dermatoses, and other rheumatoid arthritis rashes, their symptoms, and when ...

Medicinal Leaves To Cure Rheumatoid Arthritis Pain: Rheumatoid arthritis, commonly known as RA, is a chronic autoimmune disorder that leads to severe tissue inflammation, pain, and stiffness in ...